tradingkey.logo
搜尋

Standard BioTools Inc

LAB
添加自選
0.868USD
-0.029-3.27%
收盤 07-31 16:00美東報價延遲15分鐘
339.79M總市值
4.34本益比TTM

關於 Standard BioTools Inc 公司

Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.

Standard BioTools Inc簡介

公司代碼LAB
公司名稱Standard BioTools Inc
上市日期Feb 10, 2011
CEOEgholm (Michael)
員工數量818
證券類型Ordinary Share
年結日Feb 10
公司地址2 Tower Place
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94080
電話16502666000
網址https://www.standardbio.com/
公司代碼LAB
上市日期Feb 10, 2011
CEOEgholm (Michael)

Standard BioTools Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
317.28K
+61.05%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
317.28K
+61.05%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

常見問題

Standard BioTools Inc的前五大股東是誰?

Standard BioTools Inc的前五大股東如下:Mr. Sean Mackay

有多少機構持有Standard BioTools Inc(LAB)的股份?

截至2026Q1,共有342家機構持有Standard BioTools Inc的股份,合計持有的股份價值約為317.36M,占公司總股份的81.30% 。與2025Q4相比,機構持股有所增加,增幅為773508.00。

哪個業務部門對Standard BioTools Inc的收入貢獻最大?

在2026Q1,Consumables業務部門對Standard BioTools Inc的收入貢獻最大,創收36.25M,占總收入的42.48% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有